Lupin receives FDA approval for famotidine injection
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lupin Ltd (LUPN)
Assess today's live Lupin Ltd (LUPN) share price, performance and insights using our live NSE: LUPN stock exchange data.
Analyse the historical data and Lupin Ltd share price performance charts on this page. Our technical summary section provides analysis on Lupin share price buy/sell indicators using real-time data (or discuss the Lupin (LUPN) stock price today with other investors in the Lupin NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE LUPN share price (ISIN: INE326A01037) to enhance your trading decisions with our free investment tools and resources.
What Is the Lupin Ltd Share Price Today?
The Lupin share price today is 2,287.40.
What Is the Stock Symbol for Lupin Ltd
The stock symbol (or 'ticker') for Lupin Ltd is "LUPN."
What Stock Exchange Does Lupin Ltd Trade On?
Lupin Ltd is listed and trades on the NSE stock exchange.
Is Lupin Ltd a Good Stock to Buy?
Determining whether Lupin Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Lupin Ltd share price performance charts on this page. Our technical summary section provides analysis on Lupin share price buy/sell indicators using real-time data (or discuss the Lupin (LUPN) stock price today with other investors in the Lupin NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE LUPN share price (ISIN: INE326A01037) to enhance your trading decisions with our free investment tools and resources.
What Is the Lupin Ltd Share Price Today?
The Lupin share price today is 2,287.40.
What Is the Stock Symbol for Lupin Ltd
The stock symbol (or 'ticker') for Lupin Ltd is "LUPN."
What Stock Exchange Does Lupin Ltd Trade On?
Lupin Ltd is listed and trades on the NSE stock exchange.
Is Lupin Ltd a Good Stock to Buy?
Determining whether Lupin Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
2,287.40
+35.00(+1.55%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,250.50
2,294.00
52 wk Range
1,836.80
2,494.00
LUPN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,250.502,294.00
52 wk Range
1,836.802,494.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LUPN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- FDA greenlights continued generic access for Micardis
- Investing.com
Pro
- Lupin receives FDA approval for famotidine injection
- Investing.com
- FDA greenlights continued generic access for Micardis
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
06/05/2026
EPS / Forecast
34.75 / 26.16
Revenue / Forecast
74.75B / 69.15B
Compare LUPN to Peers and Sector
Metrics to compare | LUPN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLUPNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.3x | 34.7x | −0.5x | |
PEG Ratio | 0.31 | 2.04 | 0.00 | |
Price/Book | 4.6x | 5.1x | 2.6x | |
Price / LTM Sales | 3.7x | 4.6x | 3.2x | |
Upside (Analyst Target) | 11.7% | 3.5% | 55.3% | |
Fair Value Upside | Unlock | 2.2% | 9.7% | Unlock |
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women’s health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consists of labs and collection centers. The company has a strategic collaboration with TB Alliance for the development and commercialization of the investigational drug Telacebec for the treatment of multiple mycobacterial diseases including tuberculosis (TB), leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lupin (NSE: LUPN) Share Price Today?
The Lupin stock price today is 2,287.40 INR.
What Stock Exchange Does Lupin (LUPN) Trade On?
Lupin is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Lupin?
The stock symbol (also called a 'ticker') for Lupin is "LUPN."
Does Lupin Pay Dividends? What’s The Current LUPN Dividend Yield?
Yes, LUPN Pays Dividends to its Shareholders. The current Lupin dividend yield is 0.53%.
What Is the Current Lupin Market Capitalisation?
As of today, Lupin (NSE: LUPN) market cap is 1.04T INR.
What Is Lupin's (LUPN) Earnings Per Share (TTM)?
The Lupin EPS is currently 116.44 (Trailing Twelve Months).
When Is the Next Lupin Earnings Date?
Lupin's next earnings report will be released on 11/08/2026.
Is LUPN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Lupin moving averages and other technical indicators, the daily buy/sell signal for LUPN stock is Neutral.
How Many Times Has Lupin Stock Split?
Lupin has split 2 times. (See the LUPN stock split history page for full effective split date and price information.)
How Many Employees Does Lupin Have?
Lupin has 24006 employees, based on their latest Companies House report.
What is the current trading status of Lupin (NSE: LUPN)?
As of 19/05/2026, Lupin (LUPN) is trading at a share price of 2,287.40 INR, with a previous close of 2,252.40 INR. The stock has fluctuated within a day range of 2,250.50 INR to 2,294.00 INR, while its 52-week range spans from 1,836.80 INR to 2,494.00 INR.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.